X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
blood pressure (9) 9
female (9) 9
male (9) 9
hypertension (8) 8
index medicus (8) 8
peripheral vascular disease (8) 8
risk factors (8) 8
middle aged (7) 7
aged (6) 6
asia (6) 6
coronary artery disease (5) 5
coronary-artery-disease (5) 5
measurement (5) 5
blood pressure control (4) 4
clinical medicine (4) 4
coronary disease - drug therapy (4) 4
coronary disease - mortality (4) 4
klinisk medicin (4) 4
medical and health sciences (4) 4
medicin och hälsovetenskap (4) 4
mortality (4) 4
prevalence (4) 4
risk (4) 4
adult (3) 3
atherosclerosis (3) 3
benzaldehydes - administration & dosage (3) 3
benzaldehydes - adverse effects (3) 3
blood pressure variability (3) 3
cardiac and cardiovascular systems (3) 3
cardiovascular-disease (3) 3
care and treatment (3) 3
coronary disease (3) 3
coronary heart disease (3) 3
cross-sectional studies (3) 3
double-blind method (3) 3
home blood pressure monitoring (3) 3
initiated anticipation medicine (3) 3
kardiologi (3) 3
lipoprotein (3) 3
management (3) 3
morning surge (3) 3
myocardial infarction (3) 3
original research (3) 3
oximes - administration & dosage (3) 3
oximes - adverse effects (3) 3
patient monitoring equipment (3) 3
phospholipase a2 inhibitors - administration & dosage (3) 3
phospholipase a2 inhibitors - adverse effects (3) 3
population (3) 3
predictor (3) 3
prospective studies (3) 3
stroke (3) 3
1-alkyl-2-acetylglycerophosphocholine esterase - metabolism (2) 2
biomarkers (2) 2
biomarkers - metabolism (2) 2
cardiovascular disease (2) 2
cardiovascular risk (2) 2
coronary disease - enzymology (2) 2
events (2) 2
guidelines (2) 2
inflammation (2) 2
isolated nocturnal hypertension (2) 2
japan (2) 2
kaplan-meier estimate (2) 2
left-ventricular hypertrophy (2) 2
lipids (2) 2
mass screening (2) 2
medicine, general & internal (2) 2
morning hypertension (2) 2
myocardial infarction - etiology (2) 2
myocardial infarction - mortality (2) 2
pakistan (2) 2
peripheral arterial disease - diagnosis (2) 2
pharmacology (2) 2
risk assessment (2) 2
stability investigators (2) 2
stroke - etiology (2) 2
stroke - mortality (2) 2
target organ damage (2) 2
treatment (2) 2
11 medical and health sciences (1) 1
24-hour blood pressure (1) 1
24‐hour blood pressure (1) 1
abi (1) 1
abridged index medicus (1) 1
abstracts (1) 1
activating-factor acetylhydrolase (1) 1
acute myocardial infarction (1) 1
adolescent (1) 1
affect (1) 1
aging (1) 1
algorithms (1) 1
all-cause mortality (1) 1
alzheimers-disease (1) 1
ambulatory blood pressure monitoring (1) 1
analysis (1) 1
angina (1) 1
angiotensin-ii receptor (1) 1
ankle brachial index (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Human Hypertension, ISSN 0950-9240, 04/2018, Volume 32, Issue 4, pp. 249 - 258
Hypertension is the leading cause of mortality throughout Asia. Home blood pressure monitoring has the potential to improve hypertension control and is a... 
MORTALITY | POPULATION | MANAGEMENT | PREDICTOR | GUIDELINES | CARDIOVASCULAR-DISEASE | RISK | PERIPHERAL VASCULAR DISEASE | PREVALENCE | MORNING HYPERTENSION | CORONARY-ARTERY-DISEASE | Hypertension | South Korea | Mortality | Analysis | Blood pressure | Diagnosis | Health aspects
Journal Article
Journal Article
by White, Harvey D and Held, Claes and Stewart, Ralph and Tarka, Elizabeth and Brown, Rebekkah and Davies, Richard Y and Budaj, Anzej and Harrington, Robert A and Steg, P. Gabriel and Ardissino, Diego and Armstrong, Paul W and Avezum, Alvaro and Aylward, Philip E and Bryce, Alfonso and Chen, Hong and Chen, Ming-Fong and Corbalan, Ramon and Dalby, Anthony J and Danchin, Nicolas and de Winter, Robbert J and Denchev, Stefan and Diaz, Rafael and Elisaf, Moses and Flather, Marcus D and Goudev, Assen R and Granger, Christopher B and Grinfeld, Liliana and Hochman, Judith S and Husted, Steen and Kim, Hyo-Soo and Koenig, Wolfgang and Linhart, Ales and Lonn, Eva and López-Sendón, José and Manolis, Athanasios J and Mohler, Emile R and Nicolau, José C and Pais, Prem and Parkhomenko, Alexander and Pedersen, Terje R and Pella, Daniel and Ramos-Corrales, Marco A and Ruda, Mikhail and Sereg, Mátyás and Siddique, Saulat and Sinnaeve, Peter and Smith, Peter and Sritara, Piyamitr and Swart, Henk P and Sy, Rody G and Teramoto, Tamio and Tse, Hung-Fat and Watson, David and Weaver, W. Douglas and Weiss, Robert and Viigimaa, Margus and Vinereanu, gos and Zhu, Junren and Cannon, Christopher P and Wallentin, Lars and Steg, Ph Gabriel and Bucan, Olga and Elfström, Charlotta and Hegg, Lisa and Jarosz, Marie and Krug-Gourley, Sue and Rudman, Jerry and Collins, Rory and Anderson, Jeffrey and DeMets, David and Ganz, Peter and Sandercock, Peter and Weber, Michael and Fisher, Marian and Buhr, Kevin and Diegel, Scott and Schultz, Melissa and Mahaffey, Kenneth W and Alexander, John H and Al-Khatib, Sana and Baron, Tomasz and Bergström, Olle and Bushnell, Cheryl and Christersson, Christina and Eggers, Kai and Fredlund, Bengt-Olov and Hagström, Emil and Hijazi, Ziad and Örndahl, Lovisa Holm and James, Stefan K and Jernberg, Tomas and Johnston, Nina and Lopez, Renato D and Mehta, Rajena H and Newby, Kristin L and Nordmark, Örjan and Oldgren, Jonas and Roe, Matthew T and Saldéen, Katarina and Stenborg, Anna and ... and The STABILITY Investigators and STABILITY Investigators and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 18, pp. 1702 - 1711
Darapladib, an oral inhibitor of lipoprotein-associated phospholipase A2, was compared with placebo in 15,828 patients with stable coronary heart disease.... 
TRIAL | LIPOPROTEIN | MEDICINE, GENERAL & INTERNAL | THERAPY | ACTIVATING-FACTOR ACETYLHYDROLASE | OXIDIZED LDL | RISK | PHOSPHOLIPASE A | ATHEROSCLEROTIC PLAQUE | INHIBITOR | CLINICAL-OUTCOMES | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Phospholipase A2 Inhibitors - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Oximes - administration & dosage | Male | Coronary Artery Disease - drug therapy | Coronary Disease - mortality | Phospholipase A2 Inhibitors - adverse effects | Benzaldehydes - adverse effects | Benzaldehydes - administration & dosage | Coronary Artery Disease - complications | Treatment Failure | Coronary Disease - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Prevention | Care and treatment | Ischemia | Dosage and administration | Research | Coronary heart disease | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Phospholipase A2 | Clinical trials | Myocardial ischemia | Cardiovascular disease | Angina | Preventive medicine | Coronary artery disease | Phospholipase | Arteriosclerosis | Death | Plasma levels | Drug therapy | Heart diseases | Plaques | Malalties cardiovasculars | Infart de miocardi | Malalties coronàries | Assaigs clínics de medicaments | Cardiovascular diseases | Drug testing | Coronary diseases | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article
Pakistan Journal of Medical and Health Sciences, ISSN 1996-7195, 01/2015, Volume 9, Issue 1, pp. 334 - 337
Journal Article